Potere N, Di Nisio M, Rizzo G, La Vella M, et al. Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation. Int J Infect Dis 2020 Aug 5. pii: S1201-9712(20)30616.
PMID: 32768701